Search Count: 198
 |
Crystal Structure Of Wt Hiv-1 Reverse Transcriptase In Complex With 5-{2-[2-(2-Oxo-4-Sulfanylidene-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy] Phenoxy}Naphthalene-2-Carbonitrile (Jlj648), A Non-Nucleoside Inhibitor
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: CL, SO4, A1BTU |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2025-09-10
Ligands: CL, SO4, A1BTU
 |
Cryo-Em Structure Of Hiv-1 Reverse Transcriptase P66 Homodimer
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Resolution:3.85 Å Release Date: 2025-09-10 Classification: VIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
 |
Cryo-Em Structure Of Hiv-1 Reverse Transcriptase P66 Homodimer In Complex With 5-{2-[2-(2-Oxo-4-Sulfanylidene-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy] Phenoxy}Naphthalene-2-Carbonitrile (Jlj648), A Non-Nucleoside Inhibitor
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Resolution:3.05 Å Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: A1BTU |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: A1BTU
 |
Cryo-Em Structure Of Hiv-1 Reverse Transcriptase P66 Homodimer In Complex With 5-{2-[2-(2-Oxo-4-Sulfanylidene-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy] Phenoxy}Naphthalene-2-Carbonitrile, A Non-Nucleoside Inhibitor, With An Additional Pocket Of Density
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Resolution:3.09 Å Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: A1BTU |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: A1BTU
 |
Cryo-Em Structure Of Hiv-1 Reverse Transcriptase P66 Tetramer In Complex With 5-{2-[2-(2-Oxo-4-Sulfanylidene-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy]Phenoxy}Naphthalene-2-Carbonitrile (Jlj648), A Non-Nucleoside Inhibitor
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Resolution:3.43 Å Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: A1BTU |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: A1BTU
 |
Crystal Structure Of Dihydrofolate Reductase (Dhfr) From The Filarial Nematode W. Bancrofti In Complex With Nadph And [2-({4-[(2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl]Benzene-1-Carbonyl}Amino)-4-Methoxyphenyl]Acetic Acid (Tsd10 Or Oed)
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2025-08-27 Classification: OXIDOREDUCTASE Ligands: NDP, OED |
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION
Release Date: 2025-08-27
Ligands: NDP, OED
 |
Crystal Structure Of Dihydrofolate Reductase (Dhfr) From The Filarial Nematode W. Bancrofti In Complex With Nadph And [2-({4-[(2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl]Benzene-1-Carbonyl}Amino)-4-Cyanophenyl]Acetic Acid (Tsd25 Or Ofd)
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2025-08-27 Classification: OXIDOREDUCTASE Ligands: NAP, OFD |
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION
Release Date: 2025-08-27
Ligands: NAP, OFD
 |
Crystal Structure Of Dihydrofolate Reductase (Dhfr) From The Filarial Nematode W. Bancrofti In Complex With Nadph And Methotrexate (Mtx)
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2025-08-27 Classification: OXIDOREDUCTASE Ligands: NAP, MTX |
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION
Release Date: 2025-08-27
Ligands: NAP, MTX
 |
Crystal Structure Of Dihydrofolate Reductase (Dhfr) From The Filarial Nematode W. Bancrofti In Complex With Nadph And Antifolate 2-({4-[(2-Amino-4-Oxo-4,7-Dihydro-1H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl]Benzene-1-Carbonyl}Amino)Benzoic Acid (Og7 Or Tsd001)
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2025-08-27 Classification: OXIDOREDUCTASE Ligands: NAP, OG7 |
Organism: Wuchereria bancrofti
Method: X-RAY DIFFRACTION
Release Date: 2025-08-27
Ligands: NAP, OG7
 |
Crystal Structure Of T21I Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of T190I Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of A173V Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of A173V/L50F Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of L50F Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of E166V/L50F Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of E166V Sars-Cov-2 Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
 |
Crystal Structure Of T21I Sars-Cov-2 Main Protease In Complex With Compound Mpro61
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN Ligands: XEK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
Ligands: XEK
 |
Crystal Structure Of T190I Sars-Cov-2 Main Protease In Complex With Compound Mpro61
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN Ligands: XEK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
Ligands: XEK
 |
Crystal Structure Of A173V/L50F Sars-Cov-2 Main Protease In Complex With Compound Mpro61
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN Ligands: XEK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
Ligands: XEK
 |
Crystal Structure Of E166V Sars-Cov-2 Main Protease In Complex With Compound Mpro61
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.78 Å Release Date: 2025-02-12 Classification: VIRAL PROTEIN Ligands: XEK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-02-12
Ligands: XEK